Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

456629

registered interest
date	01/03/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Small Businesses: Tobacco
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will commission an independent assessment of the cumulative effect of all tobacco control measures on small businesses introduced since 1 January 2006.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	29168
answer	answer is ministerial correction date of answer 04/03/2016 answer text <p>The Department assesses the impact of all proposed measures before laying legislation using standard government methodology. These assessments are set out in Impact Assessments which are scrutinised by the Regulatory Policy Committee before publication alongside the Statutory Instrument. Impact Assessments specifically look at the impacts on small and micro businesses. A number of the tobacco measures contain commitments to further review the impact of the legislation within five years of them coming into force.</p><p> </p><p>The Department assesses the impact of tobacco control measures on an ongoing basis as it develops policy and considers new measures. In September 2013, the Department published An Audit of the impact of the Department of Health’s Regulations upon business. A copy of the report is attached. The Audit report covered all regulations for which the Department has responsibility believed to have a potential cost to business, including those relating to tobacco control. As advised in the report, there is a robust cost-benefit case for the tobacco control regulations considered and experience shows that initiatives to reduce smoking prevalence work best in combination, with cumulative effects over time.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 29169 29170 question first answered 04/03/2016 13:18:01 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ29168-29169-29170 document.pdf title Audit report
tabling member	4140 label Biography information for Mr David Nuttall

433829

registered interest
date	02/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	All Party Parliamentary Group on Smoking and Health: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many items of correspondence his Department has received from (a) the Chair and (b) other members of the All Party Parliamentary Group on Smoking and Health in each of the last five years.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	18458
answer	answer is ministerial correction date of answer 10/12/2015 answer text <p>The Department would incur a disproportionate cost in calculating how many items of correspondence have been received from the All Party Parliamentary Group on Smoking and Health (APPG) in each of the last five years.</p><br /><p>592 letters from the APPG have been recorded as received by the Department’s Ministers over that period. The Group may also have written to officials direct but this information is not collected centrally.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/12/2015 16:48:18 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall

431997

registered interest
date	24/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the grants awarded by the tobacco policy team in his Department are so awarded only after competitive bids have been invited.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	17561
answer	answer is ministerial correction date of answer 02/12/2015 answer text <p>Grants made under Section 64 of the Health Services and Public Health Act 1968 can be made in a number of ways. Grants awarded to Action on Smoking and Health have been assessed as most appropriate for the non-competed route.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/12/2015 17:22:05 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall

431738

registered interest
date	23/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Action on Smoking and Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received about funding allocated by his Department to the organisation Action on Smoking and Health.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	17348
answer	answer is ministerial correction date of answer 01/12/2015 answer text <br /><p>To identify relevant representations the Department has received would result in disproportionate cost.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 01/12/2015 17:25:46 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall

431740

registered interest
date	23/11/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Tobacco
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the annual budget of the tobacco policy team in his Department is; and what proportion of that budget was spent on external grants or contracts in the last year.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	17349
answer	answer is ministerial correction date of answer 01/12/2015 answer text <p>The Tobacco Control policy team programme budget spend for 2014/15 was £848,000 of which £648,000 was spent on grants and contracts.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 01/12/2015 16:52:56 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall

418454

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ehlers-Danlos Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions his Department has had with health bodies on ensuring timely treatment for sufferers of Ehlers-Danlos syndrome.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9988
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Information on patient outcomes of those diagnosed with Ehlers-Danlos Syndrome (EDS) in London and Greater Manchester is not held centrally by the Department. EDS falls within specialised services managed by NHS England.</p><p> </p><p> </p><p> </p><p>The UK Strategy for Rare Diseases sets out the Government’s on-going commitment to ensuring that patients with rare diseases, including EDS, have access to high quality services. The Strategy is discussed regularly with health bodies including NHS England. The national specialised service for atypical or complex cases aims to reduce times to diagnosis and reduce the number of hospital appointments required to achieve a specific diagnosis.</p><p> </p><p> </p><p> </p><p>Information about the average time from diagnosis to referral for specialist treatment is not available centrally. Patients suspected of having EDS may be assessed and diagnosed in a wide range of settings. These include United Kingdom regional clinical genetics clinics and various other secondary and tertiary speciality clinics.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 9987 9989 question first answered 21/09/2015 10:00:16 answering member 4020 label Biography information for George Freeman
tabling member	4140 label Biography information for Mr David Nuttall

418457

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ehlers-Danlos Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average length of time is between the diagnosis of a patient with Ehlers-Danlos syndrome and referral for specialist treatment in (a) London and (b) Greater Manchester.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9989
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Information on patient outcomes of those diagnosed with Ehlers-Danlos Syndrome (EDS) in London and Greater Manchester is not held centrally by the Department. EDS falls within specialised services managed by NHS England.</p><p> </p><p> </p><p> </p><p>The UK Strategy for Rare Diseases sets out the Government’s on-going commitment to ensuring that patients with rare diseases, including EDS, have access to high quality services. The Strategy is discussed regularly with health bodies including NHS England. The national specialised service for atypical or complex cases aims to reduce times to diagnosis and reduce the number of hospital appointments required to achieve a specific diagnosis.</p><p> </p><p> </p><p> </p><p>Information about the average time from diagnosis to referral for specialist treatment is not available centrally. Patients suspected of having EDS may be assessed and diagnosed in a wide range of settings. These include United Kingdom regional clinical genetics clinics and various other secondary and tertiary speciality clinics.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 9987 9988 question first answered 21/09/2015 10:00:17 answering member 4020 label Biography information for George Freeman
tabling member	4140 label Biography information for Mr David Nuttall

418461

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ehlers-Danlos Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of patient outcomes of those diagnosed with Ehlers-Danlos syndrome in (a) London and (b) Greater Manchester.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9987
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Information on patient outcomes of those diagnosed with Ehlers-Danlos Syndrome (EDS) in London and Greater Manchester is not held centrally by the Department. EDS falls within specialised services managed by NHS England.</p><p> </p><p> </p><p> </p><p>The UK Strategy for Rare Diseases sets out the Government’s on-going commitment to ensuring that patients with rare diseases, including EDS, have access to high quality services. The Strategy is discussed regularly with health bodies including NHS England. The national specialised service for atypical or complex cases aims to reduce times to diagnosis and reduce the number of hospital appointments required to achieve a specific diagnosis.</p><p> </p><p> </p><p> </p><p>Information about the average time from diagnosis to referral for specialist treatment is not available centrally. Patients suspected of having EDS may be assessed and diagnosed in a wide range of settings. These include United Kingdom regional clinical genetics clinics and various other secondary and tertiary speciality clinics.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 9988 9989 question first answered 21/09/2015 10:00:13 answering member 4020 label Biography information for George Freeman
tabling member	4140 label Biography information for Mr David Nuttall